We suggest that SBE and HSP90β siRNAs exert synergistic effects in various events to attenuate malignant HCC, demonstrating that SBE should influence multiple targets, except HSP90β, which might be of major advantage in abrogating metastatic potential in HCC cells. This evidence concerns the gene HSP90AB1 and hepatocellular carcinoma.